Shares of Olin Co. (NYSE:OLN – Get Free Report) have earned a consensus recommendation of “Hold” from the fifteen analysts that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $52.73.
OLN has been the topic of several research reports. Barclays cut their price objective on Olin from $59.00 to $49.00 and set an “equal weight” rating on the stock in a research report on Monday, July 29th. UBS Group lowered their price objective on Olin from $59.00 to $51.00 and set a “neutral” rating for the company in a research report on Tuesday, July 9th. Royal Bank of Canada reduced their target price on shares of Olin from $61.00 to $52.00 and set an “outperform” rating on the stock in a research report on Monday, July 29th. Piper Sandler lowered their price target on shares of Olin from $75.00 to $57.00 and set an “overweight” rating for the company in a research report on Tuesday, July 30th. Finally, JPMorgan Chase & Co. upgraded shares of Olin from a “neutral” rating to an “overweight” rating and set a $55.00 price objective on the stock in a report on Monday, July 29th.
Get Our Latest Research Report on OLN
Olin Price Performance
Olin (NYSE:OLN – Get Free Report) last issued its quarterly earnings data on Thursday, July 25th. The specialty chemicals company reported $0.62 EPS for the quarter, missing the consensus estimate of $0.70 by ($0.08). The company had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.71 billion. Olin had a return on equity of 11.73% and a net margin of 4.26%. The firm’s revenue for the quarter was down 3.5% compared to the same quarter last year. During the same quarter last year, the company posted $1.13 earnings per share. On average, equities research analysts anticipate that Olin will post 1.61 earnings per share for the current year.
Olin Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Thursday, August 8th were issued a $0.20 dividend. The ex-dividend date of this dividend was Thursday, August 8th. This represents a $0.80 annualized dividend and a yield of 1.74%. Olin’s payout ratio is 28.78%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OLN. LRI Investments LLC bought a new position in Olin in the first quarter worth approximately $28,000. EverSource Wealth Advisors LLC increased its position in Olin by 4,375.0% in the first quarter. EverSource Wealth Advisors LLC now owns 537 shares of the specialty chemicals company’s stock worth $32,000 after buying an additional 525 shares in the last quarter. nVerses Capital LLC bought a new position in shares of Olin in the second quarter worth about $33,000. Quarry LP purchased a new position in shares of Olin during the 4th quarter valued at about $50,000. Finally, Denver PWM LLC bought a new position in shares of Olin during the 2nd quarter valued at approximately $59,000. Institutional investors own 88.67% of the company’s stock.
About Olin
Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.
Further Reading
- Five stocks we like better than Olin
- Dividend Payout Ratio Calculator
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Top Biotech Stocks: Exploring Innovation Opportunities
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.